WAVE LIFE SCIENCES LTD. Retained Earnings
WAVE LIFE SCIENCES LTD. (WVE) had Retained Earnings of -$1.42 billion as of 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-07-30
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$1.42B.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$1.35B.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$1.33B.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$1.27B.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2026-06-30 | -$1.42B 10-Q · filed 2026-07-30 | |
| 2026-03-31 | -$1.35B 10-Q · filed 2026-04-28 | |
| 2025-12-31 | -$1.33B 10-Q · filed 2026-07-30 | |
| 2025-09-30 | -$1.27B 10-Q · filed 2025-11-10 | |
| 2025-06-30 | -$1.22B 10-Q · filed 2025-07-30 | |
| 2025-03-31 | -$1.17B 10-Q · filed 2025-05-08 | |
| 2024-12-31 | -$1.12B 10-K · filed 2026-02-26 | |
| 2024-09-30 | -$1.15B 10-Q · filed 2024-11-12 | |
| 2024-06-30 | -$1.09B 10-Q · filed 2024-08-08 | |
| 2024-03-31 | -$1.06B 10-Q · filed 2024-05-10 | |
| 2023-12-31 | -$1.02B 10-K · filed 2025-03-04 | |
| 2023-09-30 | -$1.01B 10-Q · filed 2023-11-09 | |
| 2023-06-30 | -$1.02B 10-Q · filed 2023-08-03 | |
| 2023-03-31 | -$994.74M 10-Q · filed 2023-05-03 | |
| 2022-12-31 | -$967.34M 10-K · filed 2024-03-06 | |
| 2022-09-30 | -$923.63M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | -$884.62M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | -$843.33M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | -$805.51M 10-K · filed 2023-03-23 | |
| 2021-09-30 | -$770.73M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | -$764.50M 10-Q · filed 2021-08-05 | |
| 2021-03-31 | -$725.73M 10-Q · filed 2021-05-13 | |
| 2020-12-31 | -$683.27M 10-K · filed 2022-03-03 | |
| 2020-09-30 | -$654.48M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | -$621.38M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | -$580.85M 10-Q · filed 2020-05-11 | |
| 2019-12-31 | -$533.36M 10-K · filed 2021-03-04 | |
| 2019-09-30 | -$476.59M 10-Q · filed 2019-11-05 | |
| 2019-06-30 | -$425.86M 10-Q · filed 2019-08-06 | |
| 2019-03-31 | -$383.92M 10-Q · filed 2019-05-10 | |
| 2018-12-31 | -$339.72M 10-K · filed 2020-03-02 | |
| 2018-09-30 | -$301.83M 10-Q · filed 2018-11-09 | |
| 2018-06-30 | -$264.20M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | -$228.31M 10-Q · filed 2018-05-09 | |
| 2017-12-31 | -$192.72M 10-K · filed 2020-03-02 | -$192.51M 10-K · filed 2018-03-12 |
| 2017-09-30 | -$162.30M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | -$136.17M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | -$111.47M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | -$90.48M 10-K · filed 2018-03-12 | |
| 2016-09-30 | -$72.02M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | -$54.49M 10-Q · filed 2016-08-15 | |
| 2016-03-31 | -$42.92M 10-Q · filed 2016-05-16 | |
| 2015-12-31 | -$35.08M 10-K · filed 2017-03-16 | |
| 2015-09-30 | -$27.98M 10-Q · filed 2015-12-17 | |
| 2014-12-31 | -$15.88M 10-K · filed 2016-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |